David Shaw’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTA
David Shaw's ENTA Position: Q3 2026 in Review
David Shaw increased its Enanta Pharmaceuticals (ENTA) stake by 68% in Q3 2026, buying an estimated $311K and bringing the position to 57,923 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #4001.
David Shaw first reported a position in ENTA in Q3 2014 and has held it in 39 quarters since. The position peaked at $10M in Q1 2024. 129 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.
- David Shaw held 57,923 shares of Enanta Pharmaceuticals worth $763K as of Q3 2026.
- David Shaw bought 23,384 Enanta Pharmaceuticals shares in Q3 2026, an estimated $311K.
- Enanta Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4001 holding.
- David Shaw first reported a position in Enanta Pharmaceuticals in Q3 2014 and has held it in 39 quarters since.
- David Shaw's Enanta Pharmaceuticals position peaked at $10M in Q1 2024.
- 129 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.